FDA is ‘not convinced’ UniQure’s Huntington’s therapy has benefit, senior official says Company accuses agency of reversal but hopes to settle on parameters of a new trial

https://www.statnews.com/2026/03/03/uniqure-huntingtons-treatment-fda-official-comments/ By Adam FeuersteinMarch 3, 2026 Adam Feuerstein, a senior writer and biotech columnist, is the author of Adam’s Biotech Scorecard, a subscriber-only newsletter about the crossroads of drug development, business, Wall Street, and biotechnology.